Ben Guebila, Marouen
Wang, Tian
Lopes-Ramos, Camila M.
Fanfani, Viola
Weighill, Des
Burkholz, Rebekka
Schlauch, Daniel
Paulson, Joseph N.
Altenbuchinger, Michael
Shutta, Katherine H.
Sonawane, Abhijeet R.
Lim, James
Calderer, Genis
van IJzendoorn, David G.P.
Morgan, Daniel
Marin, Alessandro
Chen, Cho-Yi
Song, Qi
Saha, Enakshi
DeMeo, Dawn L.
Padi, Megha
Platig, John
Kuijjer, Marieke L.
Glass, Kimberly
Quackenbush, John http://orcid.org/0000-0002-2702-5879
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R01HL155749, K25HL140186, R01HG125975, P01HL114501, T32HL007427)
National Cancer Institute (R35CA197449, U24CA23184, P50CA127003)
National Human Genome Research Institute (R01HG011393)
American Lung Association (LCD-821824)
Norwegian research council (187615, 313932)
Norwegian Cancer Society (214871)
German Federal Ministry of Education and Research (01ZX1912C)
Article History
Received: 16 June 2022
Accepted: 15 February 2023
First Online: 9 March 2023
Declarations
:
: Not applicable.
: Not applicable.
: Daniel Schlauch is an employee of Genospace, LLC, Joseph N. Paulson is employed by N-Power Medicine, James Lim is an employee of Monoceros Biosystems, LLC, and Alessandro Marin is an employee of Expert Analytics AS. The authors declare that they have no competing interests.